Author details

Full Name

Ian F Dunn

Affiliation

ORCID

Career Start Year

1998

Papers

252

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36976102	COMMD10 Is Essential for Neural Plate Development during Embryogenesis.		2023
36288512	Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic <i>NF2</i> Mutations.	J Clin Oncol	2023
37583551	TRAF7 is an essential regulator of blood vessel integrity during mouse embryonic and neonatal development.		2023
37337112	Exciton annihilation in molecular aggregates suppressed through quantum interference.		2023
37210127	Open Surgical Approaches for Meningiomas.		2023
37021293	Novel retro-auricular myocutaneous hemicraniectomy flap: Technical note and cadaveric dissection.	World Neurosurg X	2023
37462809	The clinicopathological features and prognosis of silent corticotroph tumors: an updated systematic review and meta-analysis.		2023
37014007	Chronic cerebrospinal fluid rhinorrhea as an initial presentation of chordoma: illustrative case.		2023
37010677	Surgical strategies for intracranial meningioma in the molecular era.		2023
36937440	Specific gene expression signatures of low grade meningiomas.		2023
36937407	Clinicopathological features and prognostic outcomes of molecularly defined entities in the new edition of the WHO classification of sinonasal carcinoma.		2023
36692533	Assessment of association between lower ureteric excision technique and oncological outcomes for upper urinary tract urothelial carcinoma: retrospective analysis from the Scottish Renal Cancer Consortium.		2023
37432629	Preclinical Models of Meningioma.		2023
37051539	Editorial: Meningioma: From basic research to clinical translational study, volume II.		2023
34932393	Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline.	J Clin Oncol	2022
35768633	Primary versus secondary gliosarcoma: a systematic review and meta-analysis.	Journal of Neuro-Oncology	2022
35901678	A systematic review of the clinicopathological features and prognostic outcomes of DICER1-mutant malignant brain neoplasms.	Journal of Neurosurgery: Pediatrics	2022
35833002	Vidian Canal as a Transcranial Landmark: Anatomy, Technique, and Illustrative Cases.	Journal of Neurological Surgery, Part B: Skull Base	2022
35383697	Early Detection and Management of Venous Thrombosis in Skull Base Surgery: Role of Routine Doppler Ultrasound Monitoring.	Neurosurgery	2022
35571989	Salvage brachytherapy for multiply recurrent metastatic brain tumors: A matched case analysis.	Neurooncol Adv	2022
35561283	Radiation Therapy for Brain Metastases: ASCO Guideline Endorsement of ASTRO Guideline.	J Clin Oncol	2022
35371982	Prognostic Implication of Patient Age in H3K27M-Mutant Midline Gliomas.	Frontiers in Oncology	2022
35371417	Polymorphous low-grade neuroepithelial tumor of the young: Rare tumor and review of the literature.	Rare Tumors	2022
35426880	Posterior Clinoid Meningioma-A Formidable Entity: 2-Dimensional Operative Video.	Operative Neurosurgery	2022
35996584	Mutated KLF4(K409Q) in meningioma binds STRs and activates gene expression.	iScience	2022
35733633	Dramatic response to targeted therapy in an aggressive olfactory neuroblastoma: illustrative case.		2022
35606633	The prognostic significance of HIST1H3B/C and H3F3A K27M mutations in diffuse midline gliomas is influenced by patient age.	Journal of Neuro-Oncology	2022
35409420	Physical Forces in Glioblastoma Migration: A Systematic Review.	International Journal of Molecular Sciences	2022
35535848	Risk stratification of H3 K27M-mutant diffuse midline gliomas based on anatomical locations: an integrated systematic review of individual participant data.	Journal of Neurosurgery: Pediatrics	2022
36386516	Endoscopy-assisted high anterior cervical approach in craniovertebral junction (CVJ).	Frontiers in Surgery	2022
34298518	Boomer Sooner: neurosurgery at the University of Oklahoma.	Journal of Neurosurgery	2022
34015129	Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results.	Neuro Oncol	2022
34801160	Biology and Treatment of Meningiomas: A Reappraisal.	Hematol Oncol Clin North Am	2022
35339711	Chondrosarcoma and Chordoma of the Skull Base and Spine: Implication of Tumor Location on Patient Survival.	World Neurosurgery	2022
35299730	The Discrepancy Between Standard Histologic WHO Grading of Meningioma and Molecular Profile: A Single Institution Series.	Frontiers in Oncology	2022
34628034	Absence of Survival Improvement for Patients with Esthesioneuroblastoma Over the Past 2 Decades: A Population-Based Study.	World Neurosurgery	2022
34508644	A molecularly integrated grade for meningioma.	Neuro Oncol	2022
35195909	The prognostic significance of further genotyping H3G34 diffuse hemispheric gliomas.	Cancer	2022
34929710	Hereditary Antithrombin Deficiency: A Balancing Act of Perioperative Hemostasis and Thromboprophylaxis-A Case Report.	A&A practice	2021
33492612	Immune profiling of pituitary tumors reveals variations in immune infiltration and checkpoint molecule expression.	Pituitary	2021
34119250	Robotics in spine surgery: A systematic review.	Journal of Clinical Neuroscience	2021
34280544	Women in Neurosurgery Around the World: A Systematic Review and Discussion of Barriers, Training, Professional Development, and Solutions.	World Neurosurgery	2021
34221291	A rare giant mixed germ cell tumor of the pineal region with immature elements: Case report and review of the literature.	Rare Tumors	2021
33611710	Clinical significance of checkpoint regulator "Programmed death ligand-1 (PD-L1)" expression in meningioma: review of the current status.	J Neurooncol	2021
33770323	Consolidating the Hyams grading system in esthesioneuroblastoma - an individual participant data meta-analysis.	Journal of Neuro-Oncology	2021
34085407	Prognostic importance of IDH mutations in chondrosarcoma: An individual patient data meta-analysis.	Cancer Medicine	2021
34026641	Surgical and Peri-Operative Considerations for Brain Metastases.	Front Oncol	2021
34345819	Incidence, risk factors, and prognosis of meningiomas with distant metastases at presentation.	Neuro-Oncology Advances	2021
33205233	Risk factors for tumor recurrence and progression of spindle cell oncocytoma of the pituitary gland: a systematic review and pooled analysis.	Pituitary	2021
33065352	An Evaluation of Neurosurgical Practices During the Coronavirus Disease 2019 Pandemic.	World Neurosurgery	2021